<DOC>
	<DOCNO>NCT02963454</DOCNO>
	<brief_summary>To investigate change concentration glucose , lactate , pyruvate glycerol extracellular fluid skeletal muscle follow levosimendan administration patient septic shock .</brief_summary>
	<brief_title>Effects Levosimendan Cellular Metabolic Alterations Patients With Septic Shock</brief_title>
	<detailed_description>The study design prospective , double-blind , control , clinical trial perform multidisciplinary intensive care unit . After achieve normovolemia mean arterial pressure least 65 mmHg , 20 septic shock patient randomize receive either levosimendan 0.2 μg/kg/min , dobutamine 5 μg/kg/min . Interstitial tissue concentration lactate , pyruvate , glucose glycerol obtain use muscle microdialysis . All measurement , include data right heart catheterization obtain baseline every 6 hour follow 72 hour randomization .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Simendan</mesh_term>
	<mesh_term>Dobutamine</mesh_term>
	<criteria>patient fulfil criterion septic shock require norepinephrine ( NE ) maintain mean arterial pressure ( MAP ) least 65 mm Hg despite appropriate volume resuscitation ( pulmonary arterial occlusion pressure [ PAOP ] = 12 18 mm Hg central venous pressure [ CVP ] = 8 12 mm Hg ) pregnancy , uncontrolled hemorrhage , terminal heart failure , significant valvular heart disease , document suspect acute coronary syndrome , limitation use inotropes : leave ventricle outflow obstruction , systolic anterior motion mitral valve .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>